45 results
8-K
EX-99.1
RVNC
Revance Therapeutics Inc
9 Aug 22
Provides Corporate Update
12:00am
adequate information to ensure consistent process performance. Specifically, the SOP requires the performance of either clean-in-place (CIP), steam
8-K
EX-99.2
33mpwa66g08dsed3 ek2
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-10.1
lu3v b1qswe3q4by5
20 Nov 20
Entry into a Material Definitive Agreement
4:20pm